Nu Skin Enterprises Inc. (NYSE:NUS) shares hit a new 52-week high on Tuesday . The company traded as high as $50.14 and last traded at $50.01, with a volume of 511,656 shares changing hands. The stock had previously closed at $48.57.

A number of research analysts have weighed in on the stock. Stifel Nicolaus lifted their price target on shares of Nu Skin Enterprises from $30.00 to $34.00 and gave the company a “sell” rating in a research report on Friday, April 29th. Jefferies Group assumed coverage on shares of Nu Skin Enterprises in a research report on Friday, June 3rd. They set a “hold” rating and a $41.00 price target on the stock. Pivotal Research reaffirmed a “buy” rating and set a $55.00 price target (up from $40.00) on shares of Nu Skin Enterprises in a research report on Friday, April 29th. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $43.00 price target on the stock in a research report on Friday, April 22nd. Finally, Citigroup Inc. lifted their price target on shares of Nu Skin Enterprises from $45.00 to $52.00 and gave the company a “buy” rating in a research report on Friday, July 1st. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Nu Skin Enterprises presently has a consensus rating of “Hold” and an average target price of $44.72.

The stock has a 50 day moving average price of $43.42 and a 200 day moving average price of $37.35. The company has a market capitalization of $2.80 billion and a price-to-earnings ratio of 29.02.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Thursday, April 28th. The company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.05. The business earned $471.80 million during the quarter, compared to analyst estimates of $465.08 million. The business’s quarterly revenue was down 11.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.60 earnings per share. Equities research analysts expect that Nu Skin Enterprises Inc. will post $2.76 EPS for the current year.

A number of institutional investors have recently bought and sold shares of the stock. California State Teachers Retirement System boosted its position in Nu Skin Enterprises by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 111,382 shares of the company’s stock valued at $4,220,000 after buying an additional 1,703 shares in the last quarter. California Public Employees Retirement System boosted its position in Nu Skin Enterprises by 10.7% in the fourth quarter. California Public Employees Retirement System now owns 158,400 shares of the company’s stock valued at $6,002,000 after buying an additional 15,300 shares in the last quarter. Engineers Gate Manager LP boosted its position in Nu Skin Enterprises by 427.7% in the fourth quarter. Engineers Gate Manager LP now owns 41,159 shares of the company’s stock valued at $1,560,000 after buying an additional 33,359 shares in the last quarter. New York State Common Retirement Fund boosted its position in Nu Skin Enterprises by 11.2% in the fourth quarter. New York State Common Retirement Fund now owns 241,115 shares of the company’s stock valued at $9,136,000 after buying an additional 24,212 shares in the last quarter. Finally, Old Mutual Global Investors UK Ltd. purchased a new position in Nu Skin Enterprises during the fourth quarter valued at about $1,116,000.

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.